Enduring Clinical Remission in Refractory Celiac Disease Type II With Tofacitinib: An Open-Label Clinical Study

被引：5
|
作者：
Dieckman, Tessa [1 ,2 ]
Schumann, Michael [3 ]
Beaumont, Hanneke [2 ]
Bontkes, Hetty j. [4 ]
Koning, Frits [1 ]
Bouma, Gerd [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Immunol, Leiden, Netherlands
[2] Vrije Univ Amsterdam Amsterdam Gastroenterol Endoc, Dept Gastroenterol & Hepatol, Amsterdam UMC, Amsterdam, Netherlands
[3] Charite Univ Med Berlin, Div Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany
[4] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam UMC locat, Lab Specialized Diagnost & Res,Dept Lab Med,Med Im, Amsterdam, Netherlands
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 11期
关键词：
BUDESONIDE;
D O I：
10.1016/j.cgh.2024.05.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2334 / 2336
页数：3
相关论文
共 50 条
  • [11] Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
    Burmester, Gerd R.
    Ferraccioli, Gianfranco
    Flipo, Rene-Marc
    Monteagudo-Saez, Indalecio
    Unnebrink, Kristina
    Kary, Sonia
    Kupper, Hartmut
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (01): : 32 - 41
  • [12] Treatment of sarcoidosis with cutaneous involvement with tofacitinib: Results of an open-label clinical trial with mechanistic insight
    Damsky, W.
    Wang, A.
    Young, B.
    Miller, E.
    King, B.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 22 - 22
  • [13] Safety of dietary undenatured type II collagen: a pilot open-label overdose clinical investigation
    Shiojima, Yoshiaki
    Takahashi, Megumi
    Takahashi, Ryohei
    Moriyama, Hiroyoshi
    Maruyama, Kazuo
    Bagchi, Debasis
    Bagchi, Manashi
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2022, 12 (03): : 103 - 115
  • [14] Clinical Spectrum of Refractory Celiac Disease
    Roshan, Bakht
    Leffler, Daniel
    Shailaja, Jamma
    Dennis, Melinda
    Schuppan, Detlef
    Jeffrey, Goldsmith
    Kelly, Ciaran
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S105 - S105
  • [15] A prospective, open-label study of rituximab for remission induction in patients with refractory Wegener's granulomatosis
    Keogh, KA
    Fervenza, FC
    Ytterberg, SR
    Specks, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V187 - V187
  • [16] An open-label clinical study of nitazoxanide in the treatment of human fascioliasis
    Kabil, SM
    El Ashry, E
    Ashraf, NK
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (06): : 339 - 345
  • [17] Venlafaxine in depressed geriatric outpatients: An open-label clinical study
    Khan, A
    Rudolph, R
    Baumel, B
    Ferguson, J
    Ryan, P
    Shrivastava, R
    PSYCHOPHARMACOLOGY BULLETIN, 1995, 31 (04) : 753 - 758
  • [18] CLINICAL EFFICACY OF TOCILIZUMAB IN POLYMYALGIA RHEUMATICA: AN OPEN-LABEL STUDY
    Toussirot, E.
    Martin, A.
    Soubrier, M.
    Redeker, S.
    Regent, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 516 - 516
  • [19] SWITCHING TO ZIPRASIDONE IN THE CLINICAL PRACTICE SETTING: AN OPEN-LABEL STUDY
    Gutierrez Fraile, Miguel
    de la Gandara Martin, Jesus J.
    Bobes Garcia, Julio
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2013, 45 (02): : 125 - 142
  • [20] Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study
    Toussirot, Eric
    Martin, Antoine
    Soubrier, Martin
    Redeker, Serge
    Regent, Alexis
    Cri, Le
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345